Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00629499 | Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer | completed | Phase 2 | 63 | SCRI Development Innovations, LLCOTHER | 1 | Nov 24, 2021 | clinicaltrials |
| NCT00193206 | Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer | completed | Phase 2 | 123 | SCRI Development Innovations, LLCOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT00866905 | Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer | completed | Phase 2 | 168 | SCRI Development Innovations, LLCOTHER | 1 | Nov 22, 2021 | clinicaltrials |
| NCT00405938 | Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer | completed | Phase 2 | 79 | SCRI Development Innovations, LLCOTHER | 1 | Nov 18, 2021 | clinicaltrials |
| NCT01421017 | Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases | completed | Phase 1 / Phase 2 | 31 | NYU Langone HealthOTHER | 1 | Nov 18, 2021 | clinicaltrials |
| NCT00297596 | Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer | completed | Phase 2 | 25 | SCRI Development Innovations, LLCOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT00193050 | Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer | completed | Phase 2 | 110 | SCRI Development Innovations, LLCOTHER | 0 | Oct 26, 2021 | clinicaltrials |
| NCT01008150 | Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer | completed | Phase 2 | 141 | NSABP Foundation IncNETWORK | 5 | Oct 25, 2021 | clinicaltrials |
| NCT01466270 | Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction | completed | Phase 2 | 62 | Wake Forest University Health SciencesOTHER | 0 | Oct 20, 2021 | clinicaltrials |
| NCT03890744 | ModraDoc006/r in Patients With Breast Cancer | completed | Phase 2 | 12 | Modra PharmaceuticalsINDUSTRY | 3 | Oct 19, 2021 | clinicaltrials |
| NCT02018458 | Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer | completed | Phase 1 / Phase 2 | 10 | Baylor Research InstituteOTHER | 1 | Oct 11, 2021 | clinicaltrials |
| NCT03078751 | Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer(EarLEE-1) | completed | Phase 2 | 54 | Novartis PharmaceuticalsINDUSTRY | 1 | Oct 11, 2021 | clinicaltrials |
| NCT02366130 | Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer | completed | Phase 2 | 45 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 7, 2021 | clinicaltrials |
| NCT01705691 | Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer | completed | Phase 2 | 50 | NSABP Foundation IncNETWORK | 2 | Oct 6, 2021 | clinicaltrials |
| NCT00206427 | Neoadjuvant GW572016 to Treat Breast Cancer(GW) | completed | Phase 2 | 49 | Baylor Breast Care CenterOTHER | 1 | Sep 29, 2021 | clinicaltrials |
| NCT01535040 | Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking | completed | Phase 2 | 130 | Wake Forest University Health SciencesOTHER | 1 | Sep 28, 2021 | clinicaltrials |
| NCT02742051 | A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer | completed | Phase 2 | 40 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Sep 23, 2021 | clinicaltrials |
| NCT05053841 | Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women | completed | Phase 2 | 45 | Tanta UniversityOTHER | 0 | Sep 23, 2021 | clinicaltrials |
| NCT01097642 | Neo-Adjuvant Study in Triple Negative Breast Cancer Patients(ICE) | completed | Phase 2 | 40 | The Methodist Hospital Research InstituteOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT01593020 | Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 | completed | Phase 2 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT02073487 | Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel(TEAL) | completed | Phase 2 | 32 | The Methodist Hospital Research InstituteOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT03931928 | Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients(TAMENDOX) | completed | Phase 2 | 356 | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)OTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT01847001 | Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | completed | Phase 2 | 10 | Columbia UniversityOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT03139851 | Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide(CHEMOIMMUNE) | completed | Phase 2 | 36 | Centre Leon BerardOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT03716583 | Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer(MELADERM) | completed | Phase 2 | 48 | Dennis Bregner ZetnerOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT00041652 | Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer | completed | Phase 1 / Phase 2 | 30 | Gilead SciencesINDUSTRY | 1 | Aug 19, 2021 | clinicaltrials |
| NCT04059809 | Photobiomodulation for Breast Cancer Radiodermatitis | completed | Phase 2 / Phase 3 | 48 | AC Camargo Cancer CenterOTHER | 1 | Aug 13, 2021 | clinicaltrials |
| NCT01631552 | Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer | completed | Phase 1 / Phase 2 | 515 | Gilead SciencesINDUSTRY | 1 | Aug 12, 2021 | clinicaltrials |
| NCT02807844 | Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies | completed | Phase 1 / Phase 2 | 141 | Novartis PharmaceuticalsINDUSTRY | 11 | Aug 11, 2021 | clinicaltrials |
| NCT00574678 | Analyzing the Composition of Tears to Identify Cancer(ACT) | completed | Phase 1 / Phase 2 | 150 | University of ArkansasOTHER | 1 | Aug 5, 2021 | clinicaltrials |
| NCT01931163 | NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer(NECTAR) | completed | Phase 2 | 24 | Jenny C. Chang, MDOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT02593227 | Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer | completed | Phase 2 | 80 | Marker Therapeutics, Inc.INDUSTRY | 1 | Jul 19, 2021 | clinicaltrials |
| NCT03092934 | A Study of AK-01 (LY3295668) in Solid Tumors | completed | Phase 1 / Phase 2 | 13 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 2, 2021 | clinicaltrials |
| NCT01023477 | Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) | completed | Phase 1 / Phase 2 | 12 | Inova Health Care ServicesOTHER | 1 | Jun 29, 2021 | clinicaltrials |
| NCT03113825 | Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery | completed | Phase 2 | 92 | Avelas Biosciences, Inc.INDUSTRY | 1 | Jun 11, 2021 | clinicaltrials |
| NCT00629616 | Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer(NIMFEA) | completed | Phase 2 | 116 | UNICANCEROTHER | 1 | Jun 9, 2021 | clinicaltrials |
| NCT02505048 | A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature(RUBY) | completed | Phase 2 | 41 | UNICANCEROTHER | 1 | Jun 8, 2021 | clinicaltrials |
| NCT00208273 | Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer | completed | Phase 2 | 150 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jun 2, 2021 | clinicaltrials |
| NCT00580333 | Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer | completed | Phase 2 | 51 | Massachusetts General HospitalOTHER | 1 | May 26, 2021 | clinicaltrials |
| NCT00971945 | Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer | completed | Phase 2 | 6 | Bristol-Myers SquibbINDUSTRY | 1 | May 25, 2021 | clinicaltrials |
| NCT03411161 | S 81694 Plus Paclitaxel in Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 22 | Institut de Recherches Internationales ServierOTHER | 4 | May 25, 2021 | clinicaltrials |
| NCT02260531 | Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases | completed | Phase 2 | 36 | Dana-Farber Cancer InstituteOTHER | 1 | May 20, 2021 | clinicaltrials |
| NCT02909751 | Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer(NeoToc) | completed | Phase 2 | 80 | Vejle HospitalOTHER | 1 | May 20, 2021 | clinicaltrials |
| NCT00546156 | Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer | completed | Phase 2 | 104 | Ian E. Krop, MD, PhDOTHER | 1 | May 18, 2021 | clinicaltrials |
| NCT02186015 | Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)(SAFE-D) | completed | Phase 2 | 43 | Loyola UniversityOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT02953860 | Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer | completed | Phase 2 | 32 | University of Colorado, DenverOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT00256217 | Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women | completed | Phase 2 | 42 | Rita Sanghvi, MehtaOTHER | 1 | May 11, 2021 | clinicaltrials |
Data updated 24 days agoSource updated Nov 24, 2021source: clinicaltrials